TARS vs MSFT: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Microsoft Corp in 2026
TARS
Tarsus Pharmaceuticals Inc
$67.24
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | TARS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.88B | N/A | TARS |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 1.3% | 0.2% | TARS |
| Gross Margin | 79.0% | 68.6% | TARS |
Analyze TARS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or MSFT a better investment?
Comparing TARS and MSFT: Tarsus Pharmaceuticals Inc has a market cap of $2.88B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and MSFT?
TARS (Tarsus Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or MSFT?
TARS has higher revenue growth at 1.3% vs 0.2% for MSFT.
Which company is more profitable: TARS or MSFT?
Tarsus Pharmaceuticals Inc (TARS) has higher gross margins at 79.0% compared to 68.6% for MSFT.
Which is the larger company: TARS or MSFT?
Tarsus Pharmaceuticals Inc (TARS) is larger with a market cap of $2.88B compared to N/A for MSFT.
Should I buy TARS or MSFT in 2026?
Both TARS and MSFT have investment merit. TARS trades at $67.24 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and MSFT stock?
Key differences: Market Cap ($2.88B vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (1.3% vs 0.2%), Gross Margin (79.0% vs 68.6%).